3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Endometrial Neoplasms
5
Anorexia
3
Weight Loss
2
Endometrial Hyperplasia
2
Cachexia
2
Breast Neoplasms
2
Body Weight
2
Squamous Intraepithelial Lesions
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Body Weight Changes
1
Interventions
Pemetrexed
15
Cisplatin
13
pembrolizumab
6
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cediranib
3
Radiotherapy
3
Gemcitabine
3
Carboplatin
3
amatuximab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Everolimus
2
Drug Therapy
2
Cyclophosphamide
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tremelimumab
1
sodium thiosulfate
1
sargramostim
1
nintedanib
1
napabucasin
1
methoxyamine
1
liposomal doxorubicin
1
incomplete Freund's adjuvant
1
fresolimumab
1
durvalumab
1
defactinib
1
cixutumumab
1
bintrafusp alfa protein, human
1
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma, Malignant
×
Megestrol Acetate
×
Clear all
No trials found.